Longitudinal Magnetic Resonance Spectroscopy as Marker of Cognitive Deterioration in Mild Cognitive Impairment (Q48665796)

14 February 2018

title

Longitudinal magnetic resonance spectroscopy as marker of cognitive deterioration in mild cognitive impairment (English)

1 reference

14 February 2018

Longitudinal Magnetic Resonance Spectroscopy as Marker of Cognitive Deterioration in Mild Cognitive Impairment (English)

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

mild cognitive impairment

24 December 2024

main subject

1 reference

Nicolás Fayed

2

1 reference

14 February 2018

Pedro J. Modrego

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22323830

24 December 2024

language of work or name

English

0 references

publication date

1 December 2011

1 reference

14 February 2018

8 February 2012

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22323830

full work available at URL

24 December 2024

https://europepmc.org/articles/PMC10845573

file format

HyperText Markup Language

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22323830

https://europepmc.org/articles/PMC10845573?pdf=render

24 December 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22323830

https://doi.org/10.1177/1533317511433809

24 December 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22323830

https://journals.sagepub.com/doi/pdf/10.1177/1533317511433809

24 December 2024

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

https://journals.sagepub.com/doi/full-xml/10.1177/1533317511433809

24 December 2024

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

American Journal of Alzheimer's Disease & Other Dementias

24 December 2024

published in

1 reference

14 February 2018

volume

26

1 reference

14 February 2018

issue

8

1 reference

14 February 2018

page(s)

631-636

1 reference

14 February 2018

Mild cognitive impairment: clinical characterization and outcome

cites work

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

1H MR spectroscopy in common dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

1H MR spectroscopy using TE averaged PRESS: a more sensitive technique to detect neurodegeneration associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Probable Alzheimer disease: diagnosis with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Longitudinal metabolic and cognitive changes in mild cognitive impairment patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

MRS shows abnormalities before symptoms in familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

MRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Comparative test-retest reliability of metabolite values assessed with magnetic resonance spectroscopy of the brain. The LCModel versus the manufacturer software

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

PET of brain amyloid and tau in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

The brain's default network: anatomy, function, and relevance to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Brain glutamate levels are decreased in Alzheimer's disease: a magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

Treatment monitoring and response prediction with proton MR spectroscopy in AD

21 January 2018

series ordinal

24

1 reference

https://api.crossref.org/works/10.1177/1533317511433809

24 December 2024

Identifiers

1 reference

14 February 2018

PMC publication ID

10845573

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22323830

24 December 2024

1 reference

14 February 2018